Amgen Inc vs. Recursion Pharmaceuticals, Inc. Class A Common Stock
AMGN
Amgen Inc
$460.42 +0.03%
VS RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock
$3.68 -3.92%
Amgen Inc and Recursion Pharmaceuticals, Inc. Class A Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AMGN | RXRX | |
|---|---|---|
| Market Cap | $248.97 billion | $2.29 billion |
AMGN leads on 1 of 1 size & scale factors.
Dividend
| AMGN | RXRX | |
|---|---|---|
| Dividend Yield | 2.19% | — |
AMGN and RXRX split the dividend factors evenly.
Risk & Sentiment
| AMGN | RXRX | |
|---|---|---|
| Short Interest | 1.66% | 0.29% |
RXRX leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, RXRX overview, RXRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.